Oncotarget Impact of Dual Immunotherapies Before Surgery in HR+/HER2-negative Breast Cancer In this new study, researchers assessed the feasibility of treating HR+/HER2-negative breast cancer patients... read more June 20, 2024
Oncotarget Identifying Biomarkers for Predicting Paclitaxel Response In this research perspective, researchers discuss causal and correlative approaches to identify potential biomarkers for... read more March 28, 2024
Oncotarget How Osteopontin Stimulates Mitochondrial Biogenesis and Cancer Metastasis In this new study, researchers investigated the role of Osteopontin splice variants in cancer metastasis.—... read more January 11, 2024
Oncotarget Genetic Insights into Early Breast Cancer in Kazakhstan In this new study, researchers aimed to determine the genetic predisposition to early breast cancer... read more October 5, 2023
Oncotarget New Study Reveals Genetic Risk Factors for Cancer in Saudi Arabia Familial cancer is a fearsome reality for millions of people worldwide. While some cases of... read more June 16, 2023
Oncotarget Reaching the Brain Through the Groin: A Novel Approach to Brain Cancer In a new editorial, researchers discuss opening the blood-brain barrier and a promising new strategy... read more May 11, 2023
Oncotarget Defining the Complexity of EGFR Endocytosis in Cancer The Trending With Impact series highlights Oncotarget publications attracting higher visibility among readers around the... read more April 27, 2023
Oncotarget CRISPR Screens Identify Novel Targets for Personalized Cancer Therapy In this trending new study, researchers used CRISPR-based genome-wide screens to identify genetic determinants of... read more October 7, 2022
Oncotarget Trending With Impact: Genes Identified in Endocrine Therapy Resistance Researchers studied the dynamic behavior of gene expression during the development of endocrine therapy resistance... read more April 14, 2022
Oncotarget A Remote Weight Loss Strategy for Breast Cancer Survivors Researchers Jennifer Y. Sheng and Vered Stearns discussed the results of a study that compared... read more March 9, 2022